These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 468597)

  • 21. [Pump failure in acute heart failure. Improvement in the prognosis with vasodilator therapy].
    Meinertz T; Gilfrich HJ; Kersting F; Kasper W
    Med Welt; 1981 Apr; 32(14):445-7. PubMed ID: 7219156
    [No Abstract]   [Full Text] [Related]  

  • 22. Vasodilators in congestive heart failure.
    Spann JF
    Clin Ther; 1982; 4(5):345-57. PubMed ID: 7039839
    [No Abstract]   [Full Text] [Related]  

  • 23. [Vasodilator therapy in congestive heart failure].
    Katila M; Luomanmäki K
    Duodecim; 1980; 96(5):430-43. PubMed ID: 7449687
    [No Abstract]   [Full Text] [Related]  

  • 24. Vasodilator therapy for congestive heart failure. Lessons from mortality trials.
    Groden DL
    Arch Intern Med; 1993 Feb; 153(4):445-54. PubMed ID: 8435024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug regimens for congestive heart failure.
    Unverferth DV; Magorien RD; Leier CV
    Geriatrics; 1980 Jul; 35(7):26-33. PubMed ID: 7380254
    [No Abstract]   [Full Text] [Related]  

  • 26. Principles of treatment of left ventricular failure.
    Taylor SH; Silke B; Nelson GI
    Eur Heart J; 1982 Dec; 3 Suppl D():19-43. PubMed ID: 6761126
    [No Abstract]   [Full Text] [Related]  

  • 27. Vasodilator therapy for left ventricular failure.
    Jacobs WR; Loeb HS; Gunnar RM
    Geriatrics; 1981 Apr; 36(4):137-43. PubMed ID: 7203016
    [No Abstract]   [Full Text] [Related]  

  • 28. [Vasodilator agents in the therapy of cardiac insufficiency].
    ZFA (Stuttgart); 1980 Mar; 56(8):565-6. PubMed ID: 7415501
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapy of chronic heart failure with vasodilator agents].
    Zähringer J; Schultheiss HP
    Internist (Berl); 1986 May; 27(5):315-21. PubMed ID: 3015822
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pathophysiologic rationales for clinical management of heart failure].
    Sasayama S
    Masui; 1994 Oct; 43 Suppl():S35-43. PubMed ID: 7853665
    [No Abstract]   [Full Text] [Related]  

  • 31. [Nitrate compounds in patients awaiting heart transplantation].
    Gavazzi A
    G Ital Cardiol; 1996 Sep; 26(9):1089-94. PubMed ID: 9036051
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of vasodilator therapy in congestive heart failure. Effects on mortality.
    Greenberg B
    Cardiol Clin; 1994 Feb; 12(1):87-99. PubMed ID: 8181028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vasodilator therapy in heart failure.
    Kubo SH
    J Heart Lung Transplant; 1994; 13(4):S122-5. PubMed ID: 7947868
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effects of OP-41483.alpha-CD, a prostacyclin analog, in the treatment of congestive refractory heart failure--efficacy as a vasodilator].
    Moriuchi M; Saito S; Tamura Y; Honye J; Ando T; Kaseda N; Tsuji M; Yumikura S; Hibiya K; Ozawa Y
    Kokyu To Junkan; 1986 Feb; 34(2):195-200. PubMed ID: 3518002
    [No Abstract]   [Full Text] [Related]  

  • 35. [Digitalis, catecholamines and vasodilators in heart failure].
    Mager G; Höpp HW; Hilger HH
    Internist (Berl); 1992 Oct; 33(10):631-8. PubMed ID: 1428681
    [No Abstract]   [Full Text] [Related]  

  • 36. Blood pressure in heart failure: a love-hate relationship.
    Pfeffer MA
    J Am Coll Cardiol; 2007 Jan; 49(1):40-2. PubMed ID: 17207720
    [No Abstract]   [Full Text] [Related]  

  • 37. Milrinone: a positive inotropic vasodilator.
    Colucci WS; Jaski BE; Fifer MA; Wright RF; Braunwald E
    Trans Assoc Am Physicians; 1984; 97():124-33. PubMed ID: 6535335
    [No Abstract]   [Full Text] [Related]  

  • 38. Oral vasodilator therapy.
    Weisberger CL
    Am J Cardiol; 1979 Dec; 44(7):1413-4. PubMed ID: 506948
    [No Abstract]   [Full Text] [Related]  

  • 39. [Vasodilator therapy in management of chronic heart failure (author's transl)].
    Letac B; Champoud O; Moore N
    Therapie; 1981; 36(1):1-10. PubMed ID: 7015550
    [No Abstract]   [Full Text] [Related]  

  • 40. Concepts of peripheral circulatory control: implications for vasodilator therapy in heart failure.
    Rubin SA; Swan HJ
    Cardiovasc Clin; 1984; 14(3):19-29. PubMed ID: 6144389
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.